These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 3293940

  • 21. Antibacterial therapy in cystic fibrosis.
    Mouton JW, Kerrebijn KF.
    Med Clin North Am; 1990 May; 74(3):837-50. PubMed ID: 2186247
    [Abstract] [Full Text] [Related]

  • 22. [Strategy of antibiotic therapy by various routes of administration in the initial colonization by Pseudomonas aeruginosa].
    Châtain P.
    Rev Mal Respir; 2003 Apr; 20(2 Pt 2):S105-12. PubMed ID: 12910142
    [No Abstract] [Full Text] [Related]

  • 23. A double-blind controlled trial of anti-Pseudomonas chemotherapy of acute respiratory exacerbations in patients with cystic fibrosis.
    Hyatt AC, Chipps BE, Kumor KM, Mellits ED, Lietman PS, Rosenstein BJ.
    J Pediatr; 1981 Aug; 99(2):307-14. PubMed ID: 7019407
    [Abstract] [Full Text] [Related]

  • 24. Tobramycin and carbenicillin compared with gentamicin and carbenicillin in the treatment of infection with Pseudomonas aeruginosa in adult patients with cystic fibrosis.
    Hodson ME, Wingfield HJ, Batten JC.
    Br J Dis Chest; 1983 Jan; 77(1):71-7. PubMed ID: 6407508
    [Abstract] [Full Text] [Related]

  • 25. [Treatment of staphylococcal infection in cystic fibrosis].
    Sermet-Gaudelus I.
    Rev Mal Respir; 2003 Apr; 20(2 Pt 2):S91-9. PubMed ID: 12910140
    [No Abstract] [Full Text] [Related]

  • 26. Pharmacokinetics of antibiotics in cystic fibrosis patients with particular reference to the bronchopulmonary tree (review).
    Bergogne-Berezin E.
    Infection; 1987 Apr; 15(4):288-94. PubMed ID: 3312023
    [No Abstract] [Full Text] [Related]

  • 27. Clinical experiences with fusidic acid in cystic fibrosis patients.
    Jensen T, Lanng S, Faber M, Rosdahl VT, Høiby N, Koch C.
    J Antimicrob Chemother; 1990 Feb; 25 Suppl B():45-52. PubMed ID: 2312445
    [Abstract] [Full Text] [Related]

  • 28. Pulmonary infection in mild variant cystic fibrosis: implications for care.
    Lording A, McGaw J, Dalton A, Beal G, Everard M, Taylor CJ.
    J Cyst Fibros; 2006 May; 5(2):101-4. PubMed ID: 16426904
    [Abstract] [Full Text] [Related]

  • 29. Paranasal sinus pathogens in children with cystic fibrosis: do they relate to lower respiratory tract pathogens and is eradication successful?
    Wilson P, Lambert C, Carr SB, Pao C.
    J Cyst Fibros; 2014 Jul; 13(4):449-54. PubMed ID: 24713592
    [Abstract] [Full Text] [Related]

  • 30. Ceftazidime - a significant advance in the treatment of cystic fibrosis.
    David TJ, Phillips BM, Connor PJ.
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():337-40. PubMed ID: 6352639
    [Abstract] [Full Text] [Related]

  • 31. [Staphylococcus aureus infection: when and how to treat?].
    Sardet A.
    Rev Mal Respir; 2003 Apr; 20(2 Pt 2):S100-4. PubMed ID: 12910141
    [No Abstract] [Full Text] [Related]

  • 32. Home treatment of pulmonary infection in cystic fibrosis.
    Kuzemko JA.
    Chest; 1988 Aug; 94(2 Suppl):162S-166S. PubMed ID: 3396439
    [Abstract] [Full Text] [Related]

  • 33. Oral anti-pseudomonal antibiotics for cystic fibrosis.
    Remmington T, Jahnke N, Harkensee C.
    Cochrane Database Syst Rev; 2007 Jul 18; (3):CD005405. PubMed ID: 17636796
    [Abstract] [Full Text] [Related]

  • 34. Efficacy of antimicrobial drugs against staphylococci in cystic fibrosis.
    Brown J.
    Aust Paediatr J; 1980 Sep 18; 16(3):207-9. PubMed ID: 7225001
    [No Abstract] [Full Text] [Related]

  • 35. Respiratory tract infections in cystic fibrosis.
    Weiner DJ.
    Pediatr Ann; 2002 Feb 18; 31(2):116-23. PubMed ID: 11862722
    [No Abstract] [Full Text] [Related]

  • 36. Moxalactam-tobramycin-resistant Pseudomonas aeruginosa isolates in patients with cystic fibrosis.
    Fitzpatrick SB, Rosenstein BJ.
    Clin Pediatr (Phila); 1983 Sep 18; 22(9):628-30. PubMed ID: 6224623
    [Abstract] [Full Text] [Related]

  • 37. Gentamicin as gene therapy.
    Luft FC.
    J Mol Med (Berl); 2002 Sep 18; 80(9):543-4. PubMed ID: 12226735
    [No Abstract] [Full Text] [Related]

  • 38. A more objective approach to the evaluation of antimicrobial therapy in cystic fibrosis.
    Valletta EA, Rigo A, Bonazzi L, Zanolla L, Mastella G.
    Acta Univ Carol Med (Praha); 1990 Sep 18; 36(1-4):44-5. PubMed ID: 2130717
    [Abstract] [Full Text] [Related]

  • 39. Pharmacokinetics of antimicrobial drugs in cystic fibrosis. Beta-lactam antibiotics.
    Lietman PS.
    Chest; 1988 Aug 18; 94(2 Suppl):115S-120S. PubMed ID: 3293936
    [Abstract] [Full Text] [Related]

  • 40. The changing prevalence of pulmonary infection in adults with cystic fibrosis: A longitudinal analysis.
    Ramsay KA, Sandhu H, Geake JB, Ballard E, O'Rourke P, Wainwright CE, Reid DW, Kidd TJ, Bell SC.
    J Cyst Fibros; 2017 Jan 18; 16(1):70-77. PubMed ID: 27515017
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.